{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Is Assertio Holdings, Inc. overvalued or undervalued?
As of November 8, 2023, Assertio Holdings, Inc. is considered a risky investment due to its overvaluation, poor financial metrics, and significant underperformance compared to peers and the S&P 500.
Is Assertio Holdings, Inc. technically bullish or bearish?
As of May 12, 2025, Assertio Holdings, Inc. exhibits a mildly bearish trend overall, with daily moving averages signaling bearishness, while weekly indicators show mild bullishness, but caution is warranted due to bearish Bollinger Bands and underperformance compared to the S&P 500.
What does Assertio Holdings, Inc. do?
Assertio Holdings, Inc. is a micro-cap specialty pharmaceutical company with recent net sales of $26 million and a net loss of $14 million. It operates in the Pharmaceuticals & Biotechnology industry and has a market cap of $63.40 million.
How big is Assertio Holdings, Inc.?
As of Jun 18, Assertio Holdings, Inc. has a market capitalization of 63.40 million, with net sales of 119.00 million and a net profit of -30.61 million over the latest four quarters. The balance sheet shows shareholder's funds of 121.08 million and total assets of 284.73 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
